Y-Intercept »

Design Therapeutics shares owned by Y-Intercept

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Y-Intercept from 13F filings

Historical chart of Y-Intercept investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by Y-Intercept consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by Y-Intercept

Quarter filed Position value Share count Share price at filing
2026-06-30 $187k 13k 14.47

More positions owned by Y-Intercept

Amazon (AMZN)
Apple (AAPL)
Boston Scientific Corporation (BSX)
Microsoft Corporation (MSFT)
Space Exploration Techn Corp Class A Com Stk (SPCX)
salesforce (CRM)
Cme (CME)
Cognizant Technology Solutio Cl A (CTSH)
Intuit (INTU)
Qualcomm (QCOM)
CBOE Holdings (CBOE)
NVIDIA Corporation (NVDA)
Accenture Plc Ireland Shs Class A (ACN)
Monolithic Power Systems (MPWR)
JPMorgan Chase & Co. (JPM)

View all positions for Y-Intercept

Top funds holding Design Therapeutics

Sr One Capital Management
Logos Global Management
Baker Bros. Advisors
Driehaus Capital Management
BlackRock
Caption Management
Point72 Asset Management
Trails Edge Capital Partners
Frazier Life Sciences Management
Vivo Capital
Vanguard Capital Management
Almitas Capital
Geode Capital Management
Sofinnova Ventures
FMR

View all funds holding Design Therapeutics